Japanese probiotics company Yakult booked an increase in third-quarter sales and earnings driven by strong overseas growth.

In a regulatory filing today (30 January), Yakult revealed group-wide sales, including the contribution of Yakult’s pharmaceuticals business, rose 6% to JPY279.9bn in the three month period.

Like many Japanese food firms, Yakult is growing its international businesses to offset sluggish domestic consumption. Revenue generated overseas by Yakult’s food business climbed 20% to JPY105.97bn. Domestic food sales edged up, rising to JPY153bn from JPY152bn in the year-ago period.

Operating profit was up 15.9% to JPY29.49bn on stronger margins. Net profit rose 16.2% to JPY21.55bn.

Click here to view the statement.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.